1 September 2019 - PHARMAC has today announced it will fund three new medicines targeting three different cancers.
The company has reached a deal with pharmaceutical companies for the drugs which target ovarian cancer, breast cancer and leukaemia.
PHARMAC board chairman Steve Maharey said it was also proposing to make two long acting contraceptives available to more people and that the meningococcal ACWY vaccine (Menactra) be free for people in close living situations such as university hostels and army barracks.